| Authors: |
Colbert RA; R.A. Colbert, MD, PhD, National Institute of Arthritis, Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA; colbertr@mail.nih.gov., Carroll E; E. Carroll, JD, R. Howard, BA, C. Shafer, BS, Spondylitis Association of America, Encino, California, USA., Dubreuil M; M. Dubreuil, MD, MSc, Boston University School of Medicine, Boston, Massachusetts, USA., Gensler LS; L.S. Gensler, MD, Department of Medicine, Division of Rheumatology, University of California, San Francisco, California, USA., Haroon N; N. Haroon, MD, PhD, MBA, University of Toronto, Toronto, Ontario, Canada., Howard R; E. Carroll, JD, R. Howard, BA, C. Shafer, BS, Spondylitis Association of America, Encino, California, USA., Ogdie AR; A.R. Ogdie, MD, MSCE, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Shafer C; E. Carroll, JD, R. Howard, BA, C. Shafer, BS, Spondylitis Association of America, Encino, California, USA., Weiss PF; P.F. Weiss, MD, MSCE, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Kuhn KA; K.A. Kuhn, MD, PhD, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. |